NASDAQ: PBYI
Puma Biotechnology Inc Stock Ownership - Who owns Puma Biotechnology?

Insider buying vs selling

Have Puma Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Troy Edward WilsonDirector2026-09-145,000$9.10
$45.50kSell
Alessandra CesanoDirector2026-09-1462,150$9.12
$566.99kSell
Alessandra CesanoDirector2026-09-1450,000$2.93
$146.50kBuy
Maximo F. NouguesChief Financial Officer2026-07-069,386$8.26
$77.56kSell
Alan H. AuerbachPresident and CEO2026-07-0644,058$8.26
$364.05kSell
Douglas M. HuntOfficer2026-07-068,460$8.26
$69.90kSell
Adrian SenderowiczDirector2026-06-1227,000$7.20
$194.32kSell
Brian M. StuglikDirector2026-06-128,100$7.20
$58.31kSell
Troy Edward WilsonDirector2026-06-1210,800$7.20
$77.75kSell
Allison DorvalDirector2026-06-1211,610$7.20
$83.58kSell

1 of 2

PBYI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PBYI insiders and whales buy or sell their stock.

PBYI Shareholders

What type of owners hold Puma Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC17.20%8,879,139$84.44MInsider
Alan H. Auerbach14.07%7,261,671$69.06MInsider
Adage Capital Partners LP6.20%3,200,000$30.43MInsider
Frank Zavrl1.86%960,069$9.13MInsider
Maximo F. Nougues0.45%230,637$2.19MInsider
Douglas M. Hunt0.38%196,841$1.87MInsider
Jeffrey Jerome Ludwig0.30%156,792$1.49MInsider
Thomas Malley0.30%156,551$1.49MInsider
Alvin F. Wong0.27%141,241$1.34MInsider
Richard Paul Bryce0.24%121,662$1.16MInsider

1 of 3

PBYI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBYI0.07%42.49%Net SellingNet Selling
YDES0.00%80.49%Net BuyingNet Buying
EPRX0.04%0.00%
ARVN0.08%35.29%Net Selling
AUTL0.05%0.54%Net BuyingNet Buying

Puma Biotechnology Stock Ownership FAQ

Who owns Puma Biotechnology?

Puma Biotechnology (NASDAQ: PBYI) is owned by 0.07% institutional shareholders, 42.49% Puma Biotechnology insiders, and 57.43% retail investors. Adage Capital Partners GP LLC is the largest individual Puma Biotechnology shareholder, owning 8.88M shares representing 17.20% of the company. Adage Capital Partners GP LLC's Puma Biotechnology shares are currently valued at $85.86M.

If you're new to stock investing, here's how to buy Puma Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.